Mpzem1Dama
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Mpzem1Dama |
| Name: |
myelin protein zero; endonuclease-mediated mutation 1, Maurizio D'Antonio |
| MGI ID: |
MGI:7481966 |
| Synonyms: |
MpzD61N |
| Gene: |
Mpz Location: Chr1:170978282-170988699 bp, + strand Genetic Position: Chr1, 79.05 cM
|
| Alliance: |
Mpzem1Dama page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Humanized sequence) |
| Mutation: |
|
Single point mutation
|
| |
|
Mutation details: CRISPR/Cas9 technology generated a G to A change at position 181 resulting in an aspartate to asparagine substitution at amino acid 61 (p.D61N). In addition, a silent A to G change at position 168 and a silent A to T conversion at position 177 were introduced to prevent gRNA binding and recleavage and to eliminate a Ddel restriction enzyme site, respectively. This mutation is predicted to generate a new N-glycosylation site and causes a severe early-onset form of Charcot-Marie-Tooth type IB neuropathy in humans.
(J:335549)
|
|
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Mpz Mutation: |
28 strains or lines available
|
|
| Original: |
J:335549 Veneri FA, et al., A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism. Hum Mol Genet. 2022 Dec 16;31(24):4255-4274 |
| All: |
1 reference(s) |
|